Showing results (291-300 of 928) with videos related to

Sort By:
Pageof 93
The Journal of Nervous and Mental Disease|November 2, 2005
Personality disorders and the trimensional personality questionnaire factors in major depressive disorderAmy Farabaugh, Dost Ongur, Maurizio Fava, et al.
Psychotherapy and Psychosomatics|October 26, 2005
Antidepressant response and well-being in pre-, peri- and postmenopausal women with major depressive disorder treated with fluoxetinePaolo Cassano, Claudio N Soares, Cristina Cusin, et al.
Comprehensive Psychiatry|September 7, 2002
Melancholia and axis II comorbidityJoyce Tedlow, Megan Smith, Nicole Neault, et al.
Academic Psychiatry : the Journal of the American Association of Directors of Psychiatric Residency Training and the Association for Academic Psychiatry|July 13, 2007
Does psychiatry residency training reflect the "real world" of psychiatry practice? A survey of residency graduatesTimothy Petersen, Maurizio Fava, Jonathan E Alpert, et al.
The Journal of Clinical Psychiatry|May 4, 2004
The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates?Maurizio Fava, Craig H Mallinckrodt, Michael J Detke, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|January 25, 2016
Obsessive-Compulsive Symptoms as a Risk Factor for Suicidality in U.S. College StudentsIlana Huz, Maren Nyer, Claire Dickson, et al.
CNS Neuroscience & Therapeutics|September 23, 2009
RESEARCH: Validation of the Massachusetts General Hospital Antidepressant Treatment History Questionnaire (ATRQ)Gregory M Chandler, Dan V Iosifescu, Mark H Pollack, et al.
General Hospital Psychiatry|February 6, 2004
Quality of life assessments in major depressive disorder: a review of the literatureGeorge I Papakostas, Timothy Petersen, Yasmin Mahal, et al.
Biological Psychiatry|June 26, 2007
Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agentsGeorge I Papakostas, Michael E Thase, Maurizio Fava, et al.
Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists|August 31, 2007
Modafinil augmentation of selective serotonin reuptake inhibitor therapy in MDD partial responders with persistent fatigue and sleepinessMaurizio Fava, Michael E Thase, Charles DeBattista, et al.
Pageof 93